PMID- 36215573 OWN - NLM STAT- MEDLINE DCOM- 20230203 LR - 20230303 IS - 1535-5667 (Electronic) IS - 0161-5505 (Linking) VI - 64 IP - 2 DP - 2023 Feb TI - Fetal Dose from PET and CT in Pregnant Patients. PG - 312-319 LID - 10.2967/jnumed.122.263959 [doi] AB - When pregnancy is discovered during or after a diagnostic examination, the physician or the patient may request an estimate of the radiation dose received by the fetus as per guidelines and standard operating procedures. This study provided the imaging community with dose estimates to the fetus from PET/CT with protocols that are adapted to University of Michigan low-dose protocols for patients known to be pregnant. Methods: There were 9 patients analyzed with data for the first, second, and third trimesters, the availability of which is quite rare. These images were used to calculate the size-specific dose estimate (SSDE) from the CT scan portion and the SUV and (18)F-FDG uptake dose from the PET scan portion using the MIRD formulation. The fetal dose estimates were tested for correlation with each of the following independent measures: gestational age, fetal volume, average water-equivalent diameter of the patient along the length of the fetus, SSDE, SUV, and percentage of dose from (18)F-FDG. Stepwise multiple linear regression analysis was performed to assess the partial correlation of each variable. To our knowledge, this was the first study to determine fetal doses from CT and PET images. Results: Fetal self-doses from (18)F for the first, second, and third trimesters were 2.18 mGy (single data point), 0.74-1.82 mGy, and 0.017-0.0017 mGy, respectively. The combined SSDE and fetal self-dose ranged from 1.2 to 8.2 mGy. These types of images from pregnant patients are rare. Conclusion: Our data indicate that the fetal radiation exposure from (18)F-FDG PET and CT performed, when medically necessary, on pregnant women with cancer is low. All efforts should be made to minimize fetal radiation exposure by modifying the protocol. CI - (c) 2023 by the Society of Nuclear Medicine and Molecular Imaging. FAU - Burton, Christiane Sarah AU - Burton CS AD - St. Jude Children's Research Hospital, Memphis, Tennessee; christiane.burton@stjude.org. FAU - Frey, Kirk AU - Frey K AD - Michigan Medicine, Ann Arbor, Michigan. FAU - Fahey, Frederic AU - Fahey F AD - Children's Hospital, Boston, Massachusetts. FAU - Kaminski, Mark S AU - Kaminski MS AD - University of Michigan, Ann Arbor, Michigan; and. FAU - Brown, Richard K J AU - Brown RKJ AD - University of Utah School of Medicine, Salt Lake City, Utah. FAU - Pohlen, Judith M AU - Pohlen JM AD - Michigan Medicine, Ann Arbor, Michigan. FAU - Shulkin, Barry L AU - Shulkin BL AD - St. Jude Children's Research Hospital, Memphis, Tennessee. LA - eng PT - Journal Article DEP - 20220908 PL - United States TA - J Nucl Med JT - Journal of nuclear medicine : official publication, Society of Nuclear Medicine JID - 0217410 RN - 0Z5B2CJX4D (Fluorodeoxyglucose F18) SB - IM MH - Humans MH - Female MH - Pregnancy MH - *Positron Emission Tomography Computed Tomography MH - *Fluorodeoxyglucose F18 MH - Positron-Emission Tomography/adverse effects/methods MH - Fetus/diagnostic imaging MH - Tomography, X-Ray Computed/methods MH - Radiation Dosage OTO - NOTNLM OT - MIRD OT - PET OT - PET/CT OT - fetal dose OT - imaging OT - radiation physics EDAT- 2022/10/11 06:00 MHDA- 2023/02/04 06:00 CRDT- 2022/10/10 15:23 PHST- 2022/02/02 00:00 [received] PHST- 2022/08/23 00:00 [revised] PHST- 2022/10/11 06:00 [pubmed] PHST- 2023/02/04 06:00 [medline] PHST- 2022/10/10 15:23 [entrez] AID - jnumed.122.263959 [pii] AID - 10.2967/jnumed.122.263959 [doi] PST - ppublish SO - J Nucl Med. 2023 Feb;64(2):312-319. doi: 10.2967/jnumed.122.263959. Epub 2022 Sep 8.